DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC – Prometheus Biosciences, Inc. Transaction History
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC portfolio value:
$14.75M
portfolio value
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC quarter portfolio value change:
+109.03%
quarter
Prometheus Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 7.69M | $59.01 | 250K | |
| Q2 2022 | share | 0.00% | 0 shares | -2.38M | $28.23 | 250K | |
| Q1 2022 | share | Increase | 0.00% | 250K shares | 9.44M | $37.76 | 250K |